Five-Fold Increase in National Prevalence Rates of Attention-Deficit/Hyperactivity Disorder Medications for Children and Adolescents with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and other Psychiatric Disorders: A Danish Register-Based Study. The purpose of this study was to estimate the prevalence and time trends in prescriptions of methylphenidate, dexamphetamine, and atomoxetine in children and adolescents, within three diagnostic…

Atomoxetine has been licensed for Adults with ADHD in the UK and several European countries in June 2013 (link). It was already licensed for children and adolescents with this disorder. Atomoxetine is second choice medication for ADHD after methylphenidate in the NICE guideline (link).  This is good news for adult patients with ADHD. Hopefully the…